Lexaria Bioscience LEXX
NASDAQ LEXX
$3.20 +0.07 (+2.26%)
As of: Sep 30, 2026 · 11:29 AM EDT

Lexaria Bioscience (LEXX) Total Current Liabilities (2011 - 2026)

Updated

Lexaria Bioscience (LEXX) posted Total Current Liabilities of $383,412 for fiscal Q3 2026 (quarter ended May 31, 2026), down 74.2% from $1.49 million a year earlier but up 78.6% from the prior quarter.

Analysis

Lexaria Bioscience (LEXX) Total Current Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2025 (ended Aug 31, 2025), Lexaria Bioscience's Total Current Liabilities came in at $1.49 million, up 35.8% from FY2024.

  • Annual Total Current Liabilities has increased for four consecutive fiscal years, with a five-year compound annual growth rate of 45.9% (FY2020 to FY2025).
  • In prior fiscal years, Lexaria Bioscience's Total Current Liabilities was $1.1 million in FY2024 (+310.6%), $267,735 in FY2023 (+38.0%), $194,036 in FY2022 (+26.6%) and $153,276 in FY2021 (-32.2%).
  • Quarterly Total Current Liabilities has run from a low of $81,717 in fiscal Q2 2024 to a high of $1.82 million in fiscal Q2 2025 over five years.
  • On a year-over-year basis, Total Current Liabilities increased in five of the last seven quarters, with growth averaging 223.7%.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was fiscal Q3 2025, with growth of 853.6%; the weakest was fiscal Q2 2026, with a decline of 88.2%.
  • According to Business Quant data, Total Current Liabilities for the three prior fiscal quarters was $214,671 (Q2 2026), $1.46 million (Q1 2026) and $1.49 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Lexaria Bioscience 3.39 Mn -12.26 Mn - 383,412.00
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 383,412.00
Feb 28, 2026 214,671.00
Nov 30, 2025 1.46 Mn
Aug 31, 2025 1.49 Mn
May 31, 2025 1.49 Mn
Feb 28, 2025 1.82 Mn
Nov 30, 2024 297,798.00
Aug 31, 2024 1.10 Mn
May 31, 2024 156,048.00
Feb 29, 2024 81,717.00
Nov 30, 2023 124,523.00
Aug 31, 2023 267,735.00
May 31, 2023 1.06 Mn
Feb 28, 2023 223,131.00
Nov 30, 2022 281,520.00
Aug 31, 2022 194,036.00
May 31, 2022 206,826.00
Feb 28, 2022 165,543.00
Nov 30, 2021 237,699.00
Aug 31, 2021 153,276.00
API Access

Lexaria Bioscience Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=LEXX&period=max&api_key=YOUR_API_KEY